Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

OSL/TRMED stock hub

OSL/TRMED has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

OSL/TRMEDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.6B

Oslo Børs

Market data

Live price

Current market quote for this ticker.

Current price

OSL/TRMED

In the news

Latest news · OSL/TRMED

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-14.6

P25 n/aP50 n/aP75 n/a

ROIC-9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All OSL/TRMED market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

162

Groups with data

Currency

NOK

Showing 162 of 162 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Norway
Country code	NO
Employees	18
Employees Change	9%
Employees Change Percent	100
Enterprise value	NOK 1.6B
Exchange	Oslo Børs
Financial currency	NOK
First seen	2026-05-10
Industry	Biotechnology
Isin	NO0010597883
Last refreshed	2026-05-10
Market cap	NOK 1.6B
Price	NOK 4.41
Price currency	NOK
Rev Per Employee	46,611.11x
Sector	Healthcare
Sic	2836
Symbol	osl/TRMED
Website	https://www.thormedical.no

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.64%
EV Earnings	-27.31x
EV/FCF	-13.13x
FCF yield	-7.57%
P/B ratio	3.49x
P/S ratio	1,899.52x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	NOK 839,000
Gross Profit Growth	739%
Net Income	NOK -58M
Net Income Growth Years	0%
Pretax Margin	-7,421.69%
Profit Per Employee	NOK -3.2M
ROA	-7.75
ROCE	-10.47
ROE	-14.63
ROIC	-9.02

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	77.54%
EPS Growth Quarters	2
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	NOK 0
Assets	NOK 708.6M
Cash	NOK 180.6M
Current Assets	NOK 199.5M
Current Liabilities	NOK 43.7M
Debt	NOK 171.4M
Debt Equity	NOK 0.38
Debt FCF	NOK -1.42
Equity	NOK 456M
Interest Coverage	-115.7
Liabilities	NOK 252.6M
Long Term Assets	NOK 509.1M
Long Term Liabilities	NOK 209M
Net Cash	NOK 9.2M
Net Cash By Market Cap	NOK 0.58
Net Cash Growth	-92.52%
Net Debt Equity	NOK -0.02
Tangible Book Value	NOK 191.9M
Tangible Book Value Per Share	NOK 0.54
WACC	2.37

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.57
Net Working Capital	NOK -12.5M
Quick ratio	4.46
Working Capital	NOK 155.9M
Working Capital Turnover	NOK 0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-40.8%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	77.47%
200-day SMA	4.07
50-day SMA	4.66
50-day SMA vs 200-day SMA	50over200
All Time High	5.73
All Time High Change	-23.04%
All Time High Date	2026-04-09
All Time Low	0.85
All Time Low Change	418.82%
All Time Low Date	2024-03-06
ATR	0.24
Beta	-0.3
Beta1y	0.5
Beta2y	0.14
Ch YTD	-16
High	4.5
High52	5.73
High52 Date	2026-04-09
High52ch	-23.04%
Low	4.38
Low52	2.29
Low52 Date	2025-06-04
Low52ch	92.58%
Ma50ch	-5.28%
Price vs 200-day SMA	8.41%
RSI	41.48
RSI Monthly	64.53
RSI Weekly	50.17
Sharpe ratio	1.17x
Sortino ratio	1.88
Total Return	-40.8%
Tr YTD	-16
Tr1m	-10.55%
Tr1w	-1.56%
Tr3m	-7.26%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	NOK -69.7M
Operating margin	-8,301.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	152,853,246%
Net Borrowing	-1,078,000
Shares Insiders	8.6%
Shares Institutions	8.53%
Shares Out	361,382,299
Shares Qo Q	13.99%
Shares Yo Y	40.8%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	NOK -124.7M
Average Volume	2,495,608.7x
Bv Per Share	1.29
CAPEX	NOK -73.1M
Ch1m	-10.55
Ch1w	-1.56
Ch1y	77.47
Ch3m	-7.26
Ch6m	22.33
Change	-0.9%
Change From Open	-1.34
Close	4.45
Days Gap	0.45
Depreciation Amortization	19,522,000
Dollar Volume	4,414,621.7
Earnings Date	2026-08-28
EBIT	NOK -69.7M
EBITDA	NOK -50.1M
EPS	NOK -0.17
F Score	1
FCF	NOK -120.6M
FCF EV Yield	-7.61x
FCF Per Share	NOK -0.33
Financing CF	171,186,000
Fiscal Year End	December
Founded	2,009
Goodwill	37,216,000
Income Tax	NOK -4.3M
Investing CF	-66,479,000
Is Primary Listing	1
Last Earnings Date	2026-02-26
Last Report Date	2025-12-31
Ma150	4.39
Ma150ch	0.55%
Ma20	4.79
Ma20ch	-7.97%
Net CF	57,167,000
Next Earnings Date	2026-08-28
Open	4.47
Position In Range	25
Ppne	244,229,000
Price Date	2026-05-08
Ptbv Ratio	8.31
Relative Volume	0.4x
Revenue	839,000x
SBC By Revenue	477.59x
Share Based Comp	4,007,000
Tax By Revenue	-507.27x
Tr6m	22.33%
Volume	1,001,048
Z Score	2.06

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does OSL/TRMED pay a dividend?

Capital-return profile for this ticker.

Performance

OSL/TRMED stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns OSL/TRMED?

Insider, institutional, and short-interest positioning.

Institutional ownership

+8.5%

Share of float held by funds and institutions

Insider ownership

+8.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+40.8%

Negative means the company is buying back shares.

Technical

OSL/TRMED momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.5

Neutral momentum band

Price vs 200-day MA

+8.4%

50/200-day relationship not available

Beta (5Y)

-0.30

Less volatile than the market

Sharpe ratio

1.17

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About OSL/TRMED

Hub-level FAQ points readers to the deeper analysis pages.

What is the current osl/TRMED stock rating?

osl/TRMED is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full osl/TRMED analysis?

The full report lives at /stocks/osl/TRMED/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for osl/TRMED?

The latest report frames osl/TRMED around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the osl/TRMED page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.